CRK and non-small cell lung carcinoma: However, we cannot completely exclude the implication of other PPIA substrate proteins for PPIA’s oncogenic properties in NSCLC cells, despite we found that two known substrate proteins CrkII and TARDBP are not affected by PPIA inhibition/KO (Supplementary Fig. 12C, D).